3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Myeloid
1
Conditions
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Hematologic Diseases
1
Bone Marrow Diseases
1
Interventions
Magnetic Resonance Spectroscopy
283
Specimen Handling
278
pembrolizumab
255
Cyclophosphamide
234
Radiotherapy
229
Nivolumab
183
Cisplatin
174
Biopsy
165
Carboplatin
155
Radiosurgery
142
fludarabine
130
Blood Specimen Collection
130
Gemcitabine
120
Surveys and Questionnaires
117
Paclitaxel
115
venetoclax
112
Standard of Care
112
Dexamethasone
105
Bevacizumab
96
Radiation
95
Rituximab
91
Oxaliplatin
89
Cytarabine
88
Capecitabine
86
Drug Therapy
85
Ipilimumab
83
Doxorubicin
81
durvalumab
80
fludarabine phosphate
73
Fluorouracil
72
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Clinical Laboratory Techniques
×
90 days
×
Clear all
NCT07543432
2026-04-21
STATIC
Stiftelsen Stockholms Sjukhem
Phase NA
Recruiting
80 enrolled
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled